Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
4.870
+0.220 (4.73%)
Mar 6, 2026, 2:46 PM EST - Market open
Aldeyra Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 9.6 | 11.89 | 13.34 | 15.37 | 11.28 | |
| Research & Development | 25.66 | 48.22 | 29.46 | 47.31 | 44.94 | |
| Operating Expenses | 35.27 | 60.12 | 42.79 | 62.68 | 56.22 | |
| Operating Income | -35.27 | -60.12 | -42.79 | -62.68 | -56.22 | |
| Interest Expense | -1.91 | -1.93 | -2.07 | -1.69 | -1.74 | |
| Interest & Investment Income | 3.32 | 6.19 | 7.32 | 2.35 | 0.19 | |
| EBT Excluding Unusual Items | -33.85 | -55.85 | -37.54 | -62.02 | -57.78 | |
| Pretax Income | -33.85 | -55.85 | -37.54 | -62.02 | -57.78 | |
| Net Income | -33.85 | -55.85 | -37.54 | -62.02 | -57.78 | |
| Net Income to Common | -33.85 | -55.85 | -37.54 | -62.02 | -57.78 | |
| Shares Outstanding (Basic) | 60 | 59 | 59 | 58 | 54 | |
| Shares Outstanding (Diluted) | 60 | 59 | 59 | 58 | 54 | |
| Shares Change (YoY) | 0.96% | 0.92% | 0.92% | 8.08% | 59.11% | |
| EPS (Basic) | -0.56 | -0.94 | -0.64 | -1.06 | -1.07 | |
| EPS (Diluted) | -0.56 | -0.94 | -0.64 | -1.06 | -1.07 | |
| Free Cash Flow | -33.35 | -43.21 | -30.33 | -56.65 | -42.56 | |
| Free Cash Flow Per Share | -0.56 | -0.73 | -0.51 | -0.97 | -0.79 | |
| EBITDA | -35.01 | -59.87 | -42.53 | -62.42 | -55.96 | |
| D&A For EBITDA | 0.25 | 0.25 | 0.26 | 0.26 | 0.26 | |
| EBIT | -35.27 | -60.12 | -42.79 | -62.68 | -56.22 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.